Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;40(6):1581-1586.
doi: 10.1007/s00345-022-03970-z. Epub 2022 Feb 27.

Factors affecting hemostasis in the control of iatrogenic renal hemorrhage

Han Bao  1 , Lingjie Shao  2 , Xiaojun Man  2 , Wenda Lin  1 , Xitong Zhang  1 , Xiangjun Han  3
Affiliations

Factors affecting hemostasis in the control of iatrogenic renal hemorrhage

Han Bao et al. World J Urol. 2022 Jun.

Abstract

Purpose: To investigate factors affecting hemostasis in iatrogenic renal hemorrhage.

Methods: Seventy-three patients with iatrogenic renal hemorrhage experiencing selective renal artery angiography between Jan 2015 and Dec 2020 were enrolled in this study. The clinical features, treatment modalities and outcomes were reviewed. Factors affecting hemostasis were analyzed by univariate and multivariate models using linear regression techniques. The optimum values of the independent factors to predict postangiographic hemostasis were conducted by receiver operating characteristic (ROC) curve analysis.

Results: Of the 73 iatrogenic renal hemorrhage patients, 47 (64.4%) patients had positive angiographic findings and received therapeutic embolization. Of the patients with negative angiographic findings, 20 (76.9%) and 6 (23.1%) received conservative therapy and prophylactic embolization, respectively. The red blood cell (RBC) count (OR = 0.61, P = 0.04), the hematuria time before angiography (OR = - 0.19, P < 0.01) and treatment modality were independent factors affecting hemostasis time. The ROC curve analysis showed that the RBC count of 3.5 × 109/L and the hematuria time before angiography of 7 days were the optimum indicators. Therapeutic embolization and prophylactic embolization were protective factors affecting hemostasis time compared with conservative treatment (OR = - 1.59, P = 0.02; OR = - 3.31, P < 0.01).

Conclusions: The hematuria time before selective renal artery angiography, the RBC count, and embolization treatment are associated with rapid hemostasis. Embolization is an effective strategy for iatrogenic renal hemorrhage, and also enables rapid hemostasis in patients with negative angiographic findings.

Keywords: Embolization; Factors; Hemostasis; Iatrogenic renal hemorrhage; Selective renal artery angiography.

PubMed Disclaimer

References

    1. Wang C, Mao Q, Tan F, Shen B (2014) Superselective renal artery embolization in the treatment of renal hemorrhage. Ir J Med Sci 183(1):59–63. https://doi.org/10.1007/s11845-013-0972-4 - DOI - PubMed
    1. Guneyli S, Gok M, Bozkaya H, Cinar C, Tizro A, Korkmaz M, Akin Y, Parildar M, Oran I (2015) Endovascular management of iatrogenic renal arterial lesions and clinical outcomes. Diagn Interv Radiol 21(3):229–234. https://doi.org/10.5152/dir.2014.14286 - DOI - PubMed - PMC
    1. Deng T, Chen Y, Liu B, Laguna MP, de la Rosette J, Duan X, Wu W, Zeng G (2019) Systematic review and cumulative analysis of the managements for proximal impacted ureteral stones. World J Urol 37(8):1687–1701. https://doi.org/10.1007/s00345-018-2561-7 - DOI - PubMed
    1. Zabkowski T, Piasecki P, Zielinski H, Wieczorek A, Brzozowski K, Ziecina P (2015) Superselective renal artery embolization in the treatment of iatrogenic bleeding into the urinary tract. Med Sci Monit 21:333–337. https://doi.org/10.12659/MSM.892112 - DOI - PubMed - PMC
    1. Haochen W, Jian W, Li S, Tianshi L, Xiaoqiang T, Yinghua Z (2019) Superselective renal artery embolization for bleeding complications after percutaneous renal biopsy: a single-center experience. J Int Med Res 47(4):1649–1659. https://doi.org/10.1177/0300060519828528 - DOI - PubMed - PMC

LinkOut - more resources